Mark Rogers‐Evans

3.1k total citations
35 papers, 2.0k citations indexed

About

Mark Rogers‐Evans is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Mark Rogers‐Evans has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 19 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Mark Rogers‐Evans's work include Chemical Synthesis and Analysis (11 papers), Synthesis and Catalytic Reactions (11 papers) and Click Chemistry and Applications (6 papers). Mark Rogers‐Evans is often cited by papers focused on Chemical Synthesis and Analysis (11 papers), Synthesis and Catalytic Reactions (11 papers) and Click Chemistry and Applications (6 papers). Mark Rogers‐Evans collaborates with scholars based in Switzerland, United Kingdom and United States. Mark Rogers‐Evans's co-authors include Erick M. Carreira, Georg Wuitschik, Klaus Müller, Johannes A. Burkhard, Holger Fischer, Björn Wagner, Franz Schuler, I. Parrilla, Dong Bo Li and Henner Knust and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Materials Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Mark Rogers‐Evans

35 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Rogers‐Evans Switzerland 20 1.5k 676 238 150 140 35 2.0k
John M. Humphrey United States 21 1.7k 1.2× 1.6k 2.4× 175 0.7× 262 1.7× 302 2.2× 36 2.6k
T. G. Murali Dhar United States 24 1.1k 0.8× 668 1.0× 88 0.4× 103 0.7× 97 0.7× 67 2.0k
John Saunders United States 28 1.3k 0.9× 1.3k 1.9× 109 0.5× 125 0.8× 145 1.0× 139 3.1k
Andrew W. Thomas Switzerland 20 3.9k 2.7× 970 1.4× 214 0.9× 498 3.3× 118 0.8× 44 4.9k
Lawrence D. Wise United States 27 1.4k 1.0× 993 1.5× 51 0.2× 114 0.8× 234 1.7× 85 2.4k
Todd W. Butler United States 15 610 0.4× 476 0.7× 136 0.6× 54 0.4× 120 0.9× 23 1.1k
David C. Horwell United Kingdom 30 933 0.6× 1.7k 2.6× 77 0.3× 100 0.7× 113 0.8× 110 2.8k
Gregor J. Macdonald Belgium 25 698 0.5× 607 0.9× 102 0.4× 78 0.5× 198 1.4× 62 1.5k
Xuebin Liao China 29 2.0k 1.4× 581 0.9× 175 0.7× 342 2.3× 139 1.0× 76 2.9k
Sander G. Mills United States 30 1.2k 0.8× 1.2k 1.8× 80 0.3× 84 0.6× 123 0.9× 77 2.6k

Countries citing papers authored by Mark Rogers‐Evans

Since Specialization
Citations

This map shows the geographic impact of Mark Rogers‐Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rogers‐Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rogers‐Evans more than expected).

Fields of papers citing papers by Mark Rogers‐Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rogers‐Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rogers‐Evans. The network helps show where Mark Rogers‐Evans may publish in the future.

Co-authorship network of co-authors of Mark Rogers‐Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Rogers‐Evans. A scholar is included among the top collaborators of Mark Rogers‐Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Rogers‐Evans. Mark Rogers‐Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrison, Devin, Eric Prinssen, Mark Rogers‐Evans, et al.. (2023). Behavioral analysis through the lifespan of disc1 mutant zebrafish identifies defects in sensorimotor transformation. iScience. 26(7). 107099–107099. 4 indexed citations
2.
Schnider, Patrick, Caterina Bissantz, Andreas Bruns, et al.. (2020). Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder. Journal of Medicinal Chemistry. 63(4). 1511–1525. 39 indexed citations
3.
Ratni, Hasane, Mark Rogers‐Evans, Caterina Bissantz, et al.. (2015). Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach. Journal of Medicinal Chemistry. 58(5). 2275–2289. 40 indexed citations
4.
Rogers‐Evans, Mark, Henner Knust, Jean‐Marc Plancher, et al.. (2014). Adventures in Drug-like Chemistry Space: From Oxetanes to Spiroazetidines and Beyond!. CHIMIA International Journal for Chemistry. 68(7-8). 492–492. 29 indexed citations
5.
Woltering, Thomas J., Wolfgang Wostl, Hans Hilpert, et al.. (2013). BACE1 inhibitors: A head group scan on a series of amides. Bioorganic & Medicinal Chemistry Letters. 23(14). 4239–4243. 43 indexed citations
6.
Nettekoven, Matthias, Jürgen Fingerle, Uwe Grether, et al.. (2013). Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening. Bioorganic & Medicinal Chemistry Letters. 23(5). 1177–1181. 12 indexed citations
7.
Burkhard, Johannes A., Georg Wuitschik, Jean‐Marc Plancher, Mark Rogers‐Evans, & Erick M. Carreira. (2013). Synthesis and Stability of Oxetane Analogs of Thalidomide and Lenalidomide. Organic Letters. 15(17). 4312–4315. 61 indexed citations
8.
Li, Dong Bo, Mark Rogers‐Evans, & Erick M. Carreira. (2011). Synthesis of Novel Azaspiro[3.4]octanes as Multifunctional Modules in Drug Discovery. Organic Letters. 13(22). 6134–6136. 43 indexed citations
9.
Burkhard, Johannes A., Georg Wuitschik, Mark Rogers‐Evans, Klaus Müller, & Erick M. Carreira. (2010). Oxetanes as Versatile Elements in Drug Discovery and Synthesis. Angewandte Chemie International Edition. 49(48). 9052–9067. 338 indexed citations
10.
Burkhard, Johannes A., Carine Guérot, Henner Knust, Mark Rogers‐Evans, & Erick M. Carreira. (2010). Synthesis and Structural Analysis of a New Class of Azaspiro[3.3]heptanes as Building Blocks for Medicinal Chemistry. Organic Letters. 12(9). 1944–1947. 98 indexed citations
11.
Malherbe, P., Edilio Borroni, Luca Gobbi, et al.. (2009). Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX2 receptor. British Journal of Pharmacology. 156(8). 1326–1341. 72 indexed citations
12.
Wuitschik, Georg, Erick M. Carreira, Mark Rogers‐Evans, & Klaus Müller. (2009). ChemInform Abstract: Oxetan‐3‐one: Chemistry and Synthesis. ChemInform. 40(13). 2 indexed citations
13.
Malherbe, Pari, Edilio Borroni, Luca Gobbi, et al.. (2009). Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX2receptor. British Journal of Pharmacology. 4 indexed citations
14.
Wuitschik, Georg, Mark Rogers‐Evans, A. Buckl, et al.. (2008). Spirocyclic Oxetanes: Synthesis and Properties. Angewandte Chemie International Edition. 47(24). 4512–4515. 166 indexed citations
15.
Wuitschik, Georg, Mark Rogers‐Evans, A. Buckl, et al.. (2008). Spirocyclic Oxetanes: Synthesis and Properties. Angewandte Chemie. 120(24). 4588–4591. 51 indexed citations
16.
Wuitschik, Georg, Mark Rogers‐Evans, Klaus Müller, et al.. (2006). Oxetanes as Promising Modules in Drug Discovery. Angewandte Chemie International Edition. 45(46). 7736–7739. 192 indexed citations
17.
Wuitschik, Georg, Mark Rogers‐Evans, Klaus Müller, et al.. (2006). Titelbild: Oxetanes as Promising Modules in Drug Discovery (Angew. Chem. 46/2006). Angewandte Chemie. 118(46). 7807–7807. 1 indexed citations
18.
Bleicher, Konrad, Luke G. Green, Rainer E. Martin, & Mark Rogers‐Evans. (2004). Ligand identification for G-protein-coupled receptors: a lead generation perspective. Current Opinion in Chemical Biology. 8(3). 287–296. 31 indexed citations
19.
Snieckus, Victor, et al.. (1994). Regioselective N-methyl carbon lithiation of N-boc-methylalkylamines. Expedient synthesis of unsymmetrical amines. Tetrahedron Letters. 35(24). 4067–4070. 15 indexed citations
20.
MARPLES, B. A. & Mark Rogers‐Evans. (1989). Enantioselective lipase-catalysed hydrolysis of esters of epoxy secondary alcohols: An alternative to Sharpless oxidation. Tetrahedron Letters. 30(2). 261–264. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Humphrey Breakdown of academic impact, for papers by T. G. Murali Dhar Breakdown of academic impact, for papers by John Saunders Breakdown of academic impact, for papers by Andrew W. Thomas Breakdown of academic impact, for papers by Lawrence D. Wise Breakdown of academic impact, for papers by Todd W. Butler Breakdown of academic impact, for papers by David C. Horwell Breakdown of academic impact, for papers by Gregor J. Macdonald Breakdown of academic impact, for papers by Xuebin Liao Breakdown of academic impact, for papers by Sander G. Mills
Rankless by CCL
2026